These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15505179)

  • 1. In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients.
    Lodi R; Tonon C; Vignatelli L; Iotti S; Montagna P; Barbiroli B; Plazzi G
    Neurology; 2004 Oct; 63(8):1513-5. PubMed ID: 15505179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
    Crocker A; España RA; Papadopoulou M; Saper CB; Faraco J; Sakurai T; Honda M; Mignot E; Scammell TE
    Neurology; 2005 Oct; 65(8):1184-8. PubMed ID: 16247044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.
    Blouin AM; Thannickal TC; Worley PF; Baraban JM; Reti IM; Siegel JM
    Neurology; 2005 Oct; 65(8):1189-92. PubMed ID: 16135770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.
    Poryazova R; Schnepf B; Werth E; Khatami R; Dydak U; Meier D; Boesiger P; Bassetti CL
    Sleep; 2009 May; 32(5):607-13. PubMed ID: 19480227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitotoxic degeneration of hypothalamic orexin neurons in slice culture.
    Katsuki H; Akaike A
    Neurobiol Dis; 2004 Feb; 15(1):61-9. PubMed ID: 14751771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced hypothalamic gray matter in narcolepsy with cataplexy.
    Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S
    Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

  • 8. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
    Thannickal TC; Nienhuis R; Siegel JM
    Sleep; 2009 Aug; 32(8):993-8. PubMed ID: 19725250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.
    Tonon C; Franceschini C; Testa C; Manners DN; Poli F; Mostacci B; Mignot E; Montagna P; Barbiroli B; Lodi R; Plazzi G
    Brain Res Bull; 2009 Sep; 80(3):147-50. PubMed ID: 19463917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy-cataplexy associated with precocious puberty.
    Plazzi G; Parmeggiani A; Mignot E; Lin L; Scano MC; Posar A; Bernardi F; Lodi R; Tonon C; Barbiroli B; Montagna P; Cicognani A
    Neurology; 2006 May; 66(10):1577-9. PubMed ID: 16717224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleepiness that cannot be overcome: narcolepsy and cataplexy.
    Han F
    Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats.
    Zhang S; Lin L; Kaur S; Thankachan S; Blanco-Centurion C; Yanagisawa M; Mignot E; Shiromani PJ
    Neuroscience; 2007 Aug; 148(1):34-43. PubMed ID: 17618058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy.
    Martínez-Rodríguez JE; Sabater L; Graus F; Iranzo A; Santamaria J
    Sleep; 2007 Jan; 30(1):27-8. PubMed ID: 17310861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of hypocretin based therapy in narcolepsy.
    Takenoshita S; Sakai N; Chiba Y; Matsumura M; Yamaguchi M; Nishino S
    Expert Opin Investig Drugs; 2018 Apr; 27(4):389-406. PubMed ID: 29623725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated heart rate response is associated with hypocretin deficiency in patients with narcolepsy.
    Sorensen GL; Knudsen S; Petersen ER; Kempfner J; Gammeltoft S; Sorensen HB; Jennum P
    Sleep; 2013 Jan; 36(1):91-8. PubMed ID: 23288975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-based morphometry in hypocretin-deficient narcolepsy.
    Overeem S; Steens SC; Good CD; Ferrari MD; Mignot E; Frackowiak RS; van Buchem MA; Lammers GJ
    Sleep; 2003 Feb; 26(1):44-6. PubMed ID: 12627731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory dysfunction in narcolepsy with and without cataplexy.
    Buskova J; Klaschka J; Sonka K; Nevsimalova S
    Sleep Med; 2010 Jun; 11(6):558-61. PubMed ID: 20513636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma orexin-A is lower in patients with narcolepsy.
    Higuchi S; Usui A; Murasaki M; Matsushita S; Nishioka N; Yoshino A; Matsui T; Muraoka H; Ishizuka Y; Kanba S; Sakurai T
    Neurosci Lett; 2002 Jan; 318(2):61-4. PubMed ID: 11796186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.